Denali Therapeutics Inc. - DNLI

SEC FilingsOur DNLI Tweets

About Gravity Analytica

Recent News

  • 06.10.2025 - June 10, 2025 10:20 AM PDT - June 10, 2025 10:55 AM PDT : Goldman Sachs Webcast
  • 06.10.2025 - June 10, 2025 10:20 AM PDT - June 10, 2025 10:55 AM PDT : Goldman Sachs Webcast
  • 06.04.2025 - June 4, 2025 6:55 AM PDT - June 4, 2025 7:25 AM PDT : Jefferies Webcast
  • 06.04.2025 - June 4, 2025 6:55 AM PDT - June 4, 2025 7:25 AM PDT : Jefferies Webcast
  • 06.04.2025 - Julian C. Baker
  • 05.13.2025 - May 13, 2025 2:20 PM PDT - May 13, 2025 2:50 PM PDT : BofA Securities 2025 Health Care Conference
  • 05.13.2025 - May 13, 2025 2:20 PM PDT - May 13, 2025 2:50 PM PDT : BofA Securities 2025 Health Care Conference
  • 05.06.2025 - Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome
  • 05.06.2025 - Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome
  • 05.06.2025 - Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome

Recent Filings

  • 06.03.2025 - 8-K Current report
  • 05.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.06.2025 - 8-K Current report
  • 05.06.2025 - EX-99.1 EX-99.1
  • 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 04.17.2025 - ARS Annual Report to Security Holders
  • 04.17.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.17.2025 - DEF 14A Other definitive proxy statements
  • 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors